“…[1][2][3][4][5][6] In the UK, Australia, Canada, Norway and New Zealand, the individualised prescribing of injectable anticipatory medications, ahead of potentual need, for people approaching the end of life in the community is widely promoted to optimise symptom control in the last days of life at home and prevent unwanted hospital admissions. [7][8][9][10][11][12][13] Anticipatory medications are kept in the home, where they are available to be administered by visiting nurses or doctors if the patient is unable to take oral medications and develops symptoms of pain, breathlessness, nausea and vomiting, agitation or respiratory secretions at the end of life. 7,14,15 Although anticipatory prescribing is recommended practice in several countries 8,9,12,13 there is inadequate evidence of its clinical effectiveness and limited research into the incidence and timing of prescriptions.…”